Overview
Lars Ronnstrand practices in Lund, Sweden. Mr. Ronnstrand is rated as an Advanced expert by MediFind in the treatment of Acute Myeloid Leukemia (AML). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Mast Cell Activation Syndrome (MCAS), and Cerebral Hypoxia.
His clinical research consists of co-authoring 68 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 22 articles in the study of Acute Myeloid Leukemia (AML).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)Mr. Ronnstrand isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaMr. Ronnstrand isAdvanced. Learn about Leukemia.
- Mast Cell Activation Syndrome (MCAS)Mr. Ronnstrand isAdvanced. Learn about Mast Cell Activation Syndrome (MCAS).
- Experienced
- Cerebral HypoxiaMr. Ronnstrand isExperienced. Learn about Cerebral Hypoxia.
- MelanomaMr. Ronnstrand isExperienced. Learn about Melanoma.